Biomicrofluidic innovations and applications in precision medicine: Highlights from IEEE-NANOMED2023

Affiliations

¹ Department of Biomedical Engineering, Chang Gung University, Taoyuan, 333, Taiwan.
² Micro/Bio/Nanofluidics Unit, Okinawa Institute of Science and Technology Graduate University, Onna-son, Okinawa, 904-0495 Japan.

Editorial

Kin Fong Lei et al. Biomicrofluidics. 2025.

. 2025 Jul 1;19(4):040402.

doi: 10.1063/5.0279314. eCollection 2025 Jul.

¹ Department of Biomedical Engineering, Chang Gung University, Taoyuan, 333, Taiwan.
² Micro/Bio/Nanofluidics Unit, Okinawa Institute of Science and Technology Graduate University, Onna-son, Okinawa, 904-0495 Japan.

No abstract available

References

1. European Medicines Agency, “New Approach Methodologies EU-IN Horizon Scanning Report” (2025).
1. New Alternative Methods Subcommittee to Science Board of FDA, “Potential Approaches to Drive Future Integration of New Alternative Methods for Regulatory Decision-Making” (2024).
1. Ramirez-Alvarado G., Garibaldi G., Toujani C., and Sun G., “In situ 3D polymerization (IS-3DP): Implementing an aqueous two-phase system for the formation of 3D objects inside a microfluidic channel,” Biomicrofluidics 18(5), 054113 (2024). 10.1063/5.0226620 - DOI - PMC - PubMed
1. Nguyen T. H., Ezzo N., Chan S., Yim E. K. F., and Ren C. L., “A simple guideline for designing droplet microfluidic chips to achieve an improved single (bio)particle encapsulation rate using a stratified flow-assisted particle ordering method,” Biomicrofluidics 18(5), 054110 (2024). 10.1063/5.0219528 - DOI - PMC - PubMed
1. Tsai H.-F. and Shen A. Q., “Impact of dcEF on microRNA profiles in glioblastoma and exosomes using a novel microfluidic bioreactor,” Biomicrofluidics 18(6), 064106 (2024). 10.1063/5.0228901 - DOI - PMC - PubMed